CNBX
CNBX Pharmaceuticals Inc

476
Loading...
Loading...
CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. Its products include Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS), and RCC-33, an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC). The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2

Frequently Asked Questions

What is Market Cap of CNBX Pharmaceuticals Inc?
What is the 52-week high for CNBX Pharmaceuticals Inc?
What is the 52-week low for CNBX Pharmaceuticals Inc?
What is CNBX Pharmaceuticals Inc stock price today?
What was CNBX Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of CNBX Pharmaceuticals Inc?
What is the Price-to-Book ratio of CNBX Pharmaceuticals Inc?
What is the 50-day moving average of CNBX Pharmaceuticals Inc?
How many employess does CNBX Pharmaceuticals Inc has?

Latest CNBX News

View
No CNBX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.